Atrial Fibrillation: all 3,957 studies

Page 13 of 40. Open to participants first (933), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the Amigo Robotic System for Ablation of the Cavo-Tricuspid IsthmusCompletedNCT02467179Not applicableResults posted
• Evaluation of the CIRCA Monitoring System in Prevention of Esophageal Lesions Following RFCACompletedNCT02467166Not applicableResults posted
• Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial FibrillationCompletedNCT02459574Not applicableResults posted
• Safety and Efficacy of Vanoxerine for the Conversion of Subjects With Recent Onset Atrial Fibrillation or Flutter to Normal Sinus RhythmTerminatedNCT02454283Phase 3Results posted
• Amplatzer™Amulet™ Post-Market Study (Amulet™PMS)CompletedNCT02447081Results posted
• Postmarket Evaluation of the Phased Radio Frequency Ablation System (GOLD AF Registry)CompletedNCT02433613Results posted
• Evaluation the Effectiveness of the Risk Minimisation Activities in the Treatment of Stroke Prevention in Atrial FibrillationCompletedNCT02433366Results posted
• Post-Embolic Rhythm Detection With Implantable Versus External MonitoringCompletedNCT02428140Not applicableResults posted
• A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the HeartCompletedNCT02415400Phase 4Results posted
• Topera C-FIRM RegistryCompletedNCT02407249Results posted
• Pivotal Study Of A Dual Epicardial & Endocardial Procedure (DEEP) ApproachCompletedNCT02393885Not applicableResults posted
• Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF)CompletedNCT02391337Phase 4Results posted
• Topera E-FIRM RegistryCompletedNCT02386345Results posted
• PRescriptiOn PattERns Of Oral AnticoagulantsCompletedNCT02366338Results posted
• SMART-SF Radiofrequency Ablation Safety StudyCompletedNCT02359890Phase 3Results posted
• Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)CompletedNCT02348723Phase 4Results posted
• ABLATOR Ablation Observational RegistryCompletedNCT02344173Results posted
• TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval StudyCompletedNCT02310100Not applicableResults posted
• Multipolar Mapping and Atrial ArrhythmiasCompletedNCT02307188Not applicableResults posted
• Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic TransformationCompletedNCT02283294Phase 3Results posted
• Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided ProceduresCompletedNCT02274857Not applicableResults posted
• The Influence of Heart Rate Limitation on Exercise Tolerance in Pacemaker Patients.CompletedNCT02247245Not applicableResults posted
• Drug Persistence/Adherence in Patients Treated With Dabigatran or VKA for Stroke Prevention in Non Valvular Atrial Fibrillation (SPAF)CompletedNCT02240667Results posted
• Evaluation of Potential Off-label Use of Dabigatran Etexilate in EuropeCompletedNCT02240654Results posted
• Occult Paroxysmal Atrial Fibrillation in Non-Cryptogenic Ischemic StrokeCompletedNCT02232022Not applicableResults posted
• Cardiac Resynchronization Therapy Efficacy EnhancementsCompletedNCT02222818Not applicableResults posted
• Comparison of Intracardiac Echocardiography and Transesophageal EchocardiographyCompletedNCT02213666Results posted
• An Assessment of Dual Site Left Ventricular Endocardial PacingCompletedNCT02211456Not applicableResults posted
• OFDI Capsule Imaging in Patients With Atrial Fibrillation Undergone Radio Frequency (RF) AblationCompletedNCT02204566Not applicableResults posted
• D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial FibrillationCompletedNCT02199080Not applicableResults posted
• Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial FibrillationTerminatedNCT02177266Phase 3Results posted
• Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)CompletedNCT02164864Phase 3Results posted
• A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial FibrillationTerminatedNCT02156076Phase 2Results posted
• Management of Major Bleeding Events in Atrial Fibrillation Patients Using PradaxaCompletedNCT02149303Results posted
• Rate Control Versus Rhythm Control For Postoperative Atrial FibrillationCompletedNCT02132767Phase 3Results posted
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)CompletedNCT02100228Phase 4Results posted
• Substrate Ablation Guided by High Density Mapping in Atrial FibrillationCompletedNCT02093949Results posted
• Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable PlaqueCompletedNCT02090075Phase 4Results posted
• Sequential Expansion of Comparative Effectiveness of AnticoagulantsCompletedNCT02081807Results posted
• Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)CompletedNCT02072434Phase 3Results posted
• A Trial to Determine the Safety, Pharmacokinetics, and Efficacy of OPC-108459 Administered as a Single Intravenous Dose to Patients With Paroxysmal or Persistent Atrial Fibrillation (AF)CompletedNCT02069119Phase 1Results posted
• Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial FibrillationCompletedNCT02064764Not applicableResults posted
• The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare CoverageCompletedNCT02061748Results posted
• The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare CoverageCompletedNCT02043808Results posted
• Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial FibrillationCompletedNCT02042534Phase 2Results posted
• Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using PradaxaCompletedNCT02022020Results posted
• Stroke Feasibility StudyCompletedNCT01997905Phase 1/2Results posted
• The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) StudyCompletedNCT01996943Not applicableResults posted
• Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot StudyCompletedNCT01985425Phase 3Results posted
• CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF)CompletedNCT01984346Not applicableResults posted
• Use of Dabigatran Etexilate to Prevent Stroke and ThromboembolismCompletedNCT01976507Phase 4Results posted
• Registry on WATCHMAN Outcomes in Real-Life UtilizationCompletedNCT01972282Results posted
• Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart FailureCompletedNCT01970501Phase 2Results posted
• Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor SystemCompletedNCT01965899Not applicableResults posted
• Oral Anticoagulation Therapy Pilot StudyTerminatedNCT01959425Phase 4Results posted
• Adenosine Effect on Persistent Pulmonary Vein Isolation Line Evaluation (APPLE Trial)CompletedNCT01932112Phase 3Results posted
• Integrated Management Program Advancing Community Treatment of Atrial FibrillationCompletedNCT01927367Not applicableResults posted
• Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial FibrillationCompletedNCT01924065Phase 3Results posted
• Comparison of Diltiazem and Metoprolol in the Management of Acute Atrial Fibrillation or Atrial FlutterCompletedNCT01914926Phase 4Results posted
• A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF RecurrenceCompletedNCT01907828Not applicableResults posted
• Vein of Marshall Ethanol Infusion for Persistent Atrial FibrillationCompletedNCT01898221Phase 3Results posted
• Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal FunctionCompletedNCT01896297Phase 4Results posted
• The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart FailureTerminatedNCT01887353Phase 2Results posted
• Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)CompletedNCT01884350Phase 4Results posted
• Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation PostoperativelyTerminatedNCT01868243Phase 2/3Results posted
• Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal ImpairmentCompletedNCT01857622Phase 3Results posted
• Anticoagulant Utilization PatternCompletedNCT01847560Results posted
• Comparative Effectiveness of Oral AnticoagulantsCompletedNCT01847547Results posted
• Atrial Pressure Electrophysiology Pilot StudyTerminatedNCT01845974Not applicableResults posted
• Cryoablation of AF: Improving the Use of the Achieve CatheterCompletedNCT01843465Results posted
• Efficacy and Safety Study of F373280CompletedNCT01831856Phase 2Results posted
• A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary InterventionCompletedNCT01830543Phase 3Results posted
• nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial FibrillationTerminatedNCT01824394Phase 3Results posted
• SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of KoreaCompletedNCT01774370Results posted
• Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure TechnologyCompletedNCT01760291Not applicableResults posted
• Colchicine and CRP in Atrial Fibrillation and AF AblationCompletedNCT01755949Phase 2Results posted
• A Study Exploring Two Treatment Strategies in Patients With Atrial Fibrillation Who Undergo Catheter Ablation TherapyCompletedNCT01729871Phase 3Results posted
• REVEAL AF: Incidence of AF in High Risk PatientsCompletedNCT01727297Not applicableResults posted
• Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal ImpairmentCompletedNCT01721837Results posted
• Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial AppendageCompletedNCT01721447Phase 4Results posted
• Genetically Determined Response to Atenolol in Patients With Persistent Atrial FibrillationCompletedNCT01719367Not applicableResults posted
• CARTO® 3 System and Real Time Intracardiac UltrasoundCompletedNCT01716663Results posted
• Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation PatientsCompletedNCT01710254Phase 2Results posted
• Rhythm Evaluation for AntiCoagulaTion With COntinuous MonitoringCompletedNCT01706146Phase 4Results posted
• ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial FibrillationCompletedNCT01694563Not applicableResults posted
• Evaluation of the Phased Radio Frequency Ablation SystemTerminatedNCT01693120Not applicableResults posted
• Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus RhythmCompletedNCT01691313Phase 2Results posted
• Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial FibrillationCompletedNCT01687166Not applicableResults posted
• Cryoablation of Atrial Fibrillation Using a Novel Cryoablation SystemCompletedNCT01687036Not applicableResults posted
• Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for CardioversionCompletedNCT01674647Phase 3Results posted
• DEtermining Accuracy and TrEnding CharacTerization of AFCompletedNCT01673256Results posted
• GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)CompletedNCT01671007Results posted
• Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)CompletedNCT01661205Not applicableResults posted
• Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures StudyCompletedNCT01656772Phase 3Results posted
• Improving Anticoagulation Control in VISN 1CompletedNCT01653405Not applicableResults posted
• Safety Study on Stopping Anticoagulation Medication in Patients With a History of Atrial FibrillationTerminatedNCT01650298Not applicableResults posted
• THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESSCompletedNCT01639495Phase 3Results posted
• Adjunctive Renal Denervation in the Treatment of Atrial FibrillationCompletedNCT01635998Not applicableResults posted
• Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation TrialCompletedNCT01597557Not applicableResults posted
• Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial FibrillationTerminatedNCT01590979Not applicableResults posted

← Atrial Fibrillation overview